Amicogen Inc
Amicogen, Inc. operates as an industrial biotechnology company in South Korea and internationally. The company develops, produces, and sells of enzymes and new materials; and produces food-related additives and health functional food. It manufactures and sells of biopharmaceutical materials and resins for purifying pharmaceutical proteins and health and beauty products. In addition, the company o… Read more
Amicogen Inc (092040) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.022x
Based on the latest financial reports, Amicogen Inc (092040) has a cash flow conversion efficiency ratio of -0.022x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-2.22 Billion) by net assets (₩101.34 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Amicogen Inc - Cash Flow Conversion Efficiency Trend (2014–2024)
This chart illustrates how Amicogen Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Amicogen Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Amicogen Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
D0X
F:D0X
|
-0.041x |
|
Taokaenoi Food & Marketing Public Company Limited
BK:TKN
|
0.148x |
|
Yangarra Resources Ltd
PINK:YGRAF
|
0.024x |
|
Los Andes Copper Ltd
OTCQX:LSANF
|
-0.003x |
|
Birlesim Muhendislik Isitma Sogutma Havalandirma Sanayi & Ticaret Sirketi AS
IS:BRLSM
|
-0.179x |
|
Auburn National Bancorporation Inc
NASDAQ:AUBN
|
0.046x |
|
TROPHY GAMES DEV. DK-020
F:4H7
|
N/A |
|
1S90
F:1S90
|
0.050x |
Annual Cash Flow Conversion Efficiency for Amicogen Inc (2014–2024)
The table below shows the annual cash flow conversion efficiency of Amicogen Inc from 2014 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩122.50 Billion | ₩-13.34 Billion | -0.109x | -375.82% |
| 2023-12-31 | ₩218.97 Billion | ₩8.64 Billion | 0.039x | +123.21% |
| 2022-12-31 | ₩131.80 Billion | ₩-22.41 Billion | -0.170x | -492.13% |
| 2021-12-31 | ₩186.16 Billion | ₩8.07 Billion | 0.043x | -25.19% |
| 2020-12-31 | ₩152.94 Billion | ₩8.87 Billion | 0.058x | -19.24% |
| 2019-12-31 | ₩122.05 Billion | ₩8.76 Billion | 0.072x | +221.69% |
| 2018-12-31 | ₩127.28 Billion | ₩2.84 Billion | 0.022x | -83.25% |
| 2017-12-31 | ₩89.19 Billion | ₩11.88 Billion | 0.133x | -3.68% |
| 2016-12-31 | ₩81.54 Billion | ₩11.28 Billion | 0.138x | -8.00% |
| 2015-12-31 | ₩82.10 Billion | ₩12.34 Billion | 0.150x | +69.90% |
| 2014-12-31 | ₩50.02 Billion | ₩4.43 Billion | 0.088x | -- |